World Health Organization (WHO). Inorganic lead. Geneva: World Health Organization; Environ Health Criteria 165; 1995.
Lewis J. Leadpoisoning: A Historical Perspective. EPA Journal - May 1985. http://www.epa.gov/history/topics/perspect/lead.htm
Hernberg S. LeadPoisoning in a Historical Perspective. Am J Ind Med 2000;38,244-54.
Clark CS, Rampal KG, Thuppil V, Chen CK, Clark R, Roda S. The lead content of currently available new residential
1. Fullmer CS. Intestinal interactions of lead and calcium. Neurotoxicol. 1992; 13:799-807.
2. Godwin HA. The biological chemistry of lead. Curr Opin Chem Biol. 2001; 5:223-7.
3. DeLuca HF. Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr. 2004; 80 (6Suppl):1689S-96S.
4. Onalaja AO, Claudio L. Genetic susceptibility to leadpoisoning. Environ Health Perspect. 2000; 108 (Suppl 1):23-8.
5. Rezende VB, Barbosa F, Jr., Montenegro MF
Advisory Committee on Childhood LeadPoisoning Prevention (ACCLPP)”. CDC. (2012). Retrieved 19 sept. 2014.
Agency for Toxic Substances and Disease Registry (ATSDR). (2007). Lead Toxicity: Who Is at Risk of Lead Exposure? Environmental Health and Medicine Education . U.S. Department of Health and Human Services. Course: WB 1105.
Apostoli P, Kiss P, Porru S, Bonde JP, Vanhoorne M. (1998). Male reproductive toxicity of lead in animals and humans. ASCLEPIOS Study Group. Occup Environ Med 55 : 364–74.
Barbosa Jr F, Tanus
its reversibility. Free Rad Biol Med 51 : 257-281.
Flora SJS, Flora G, Saxena G. (2006). Environmental occurrence, health effects and management of leadpoisoning. (In: Jose, S. C, Jose, S., eds. Lead . Amsterdam: Elsevier Science B.V.). pp. 158-228.
Flora SJ, Pande M, Mehta A. (2003). Benefi cial eff ect of combined administration of some naturally occurring antioxidants (vitamins) and thiol chelators in the treatment of chronic lead intoxication. Chem Biol Interact 145 : 267-280.
Flora SJ, Flora G, Saxena G
Tanja P. Kuneva, Diana B. Apostolova, Zlatka B. Stoyneva, Aneta B. Ivanova, Vladimira V. Boyadzhieva and Kristina A. Yosifcheva
, Tsalev D. Lead levels in blood, nails and teeth as biomarkers of exposure – informational value and relevance. Bulgarian Journal of Chemistry. 2013;2(4):133-44. Bulgarian.
8. Gordon JN. Taylor A. Bennett PN. Leadpoisoning: case studies. Br J Clin Pharmacol. 2002;53(5):451-8.
9. Skerfving S, Bergdahl IA. Lead. In: Nordberg G, Fowler B, Nordberg M, Friberg L, editors. Handbook on the Toxicology of Metals. 3rd ed. NY: Academic Press; 2007. p. 599-643.
10. Sommar JN, Svensson MK, Björ BM, Elmståhl SI, Hallmans G, Lundh T, et al. End-stage renal disease
Petar Stamberov, Chavdar Zhelev, Toni Todorov, Sofiya Ivanova, Tandzhu Mehmedov, Iliyan Manev and Ella Taneva
Bellrose, F. C., 1959. Leadpoisoning as a mortality factor in waterfowl populations. Bulletin of the Illinois Natural History Survey, 27, 231-288.
Buerger, T. T., R. E. Mirarchi, M. E. Lisano, 1986. Effects of lead shot ingestion on captive mourning dove survivability and reproduction. Journal of Wildlife Management, 50, 1-8.
Butler, D. A., R. B. Sage, R. A. H. Draycott, J. P. Carroll, D. Potts. 2005. Lead exposure in ring-necked pheasants on shooting estates in Great Britain, Wildlife Society
Florentina Roncea, Horatiu Miresan, Adrian Cosmin Rosca, Mihaela Bratu and Antoanela Popescu
The present study investigated the influence of quercetol upon δ-aminolevulinic acid (△ -ALA) urine concentration as marker of lead poisoning. The study was conducted on six lots of 6 mature Wistar rats of both sexes, lots not poisoned treated with different concentrations of quercetol (Q1, Q2), control (L6M), lot poisoned untreated (L3Pb), lots poisoned and treated with Q (L4Q1Pb and L5Q2Pb). After 11 days urine from 24 hours was collected for △-ALA spectrophotometric assay and testing the significance of mean difference of by "t" test Student at p <0.05. Statistical analysis of the data presented shows that compared to L2Q2 and L6M the amount of δ-ALA excreted in urine under quercetol influence (L4Q1Pb) shows statistical significance compared to (L2Q2) the amount of δ-ALA excreted in urine compared to (L3Pb) shows statistical significance. Different concentrations of quercetol (Q1, Q2), did not produce significant changes in the δ-ALA excreted compared with values of (L3Pb). Difference between means is probably due to sampling fluctuation, is not significant, reduced growth to eliminate δ-ALA on L4Q1Pb and L5Q2Pb is believed to be due to iron complex formation, reducing hemoglobin synthesis. From the results we conclude that hem biosynthesis does not start to grow under quercetol protection. The obtained data are not relevant statistical since interpretations were performed on non homogeneous groups in number of individuals, the percentage of mortality variability and high levels of standard deviation calculated from each lot.
Imran Mohammad, Abbas Mahdi, Aryapu Raviraja, Islam Najmul, Ahmad Iqbal and Venkatesh Thuppil
Gurer-Orhan H, Sabir HU, Ozgunes H. Correlation between clinical indicator of leadpoisoning and oxidative stress parameters in controls and lead exposed workers. Toxicology 2004; 195:147-54.
Kasperczyk S, Birkner E, Kasperczyk A, Kasperczyk J. Lipids, lipid peroxidation and 7-ketocholesterol in workers exposed to lead. Hum Exp Toxicol 2005;24:287-95.
Muntener P, He J, Vupputuri S, Coresh J, Batuman V. Blood lead and chronic kidney disease in the general United States population: results from NHANES III. Kidney
Original Study. RJPBCS 3: 934-939, 2012.
15. Sies H, Jones DP . Oxidative stress. Encyclopedia of stress 3: 45-58, 2007.
16. Taylor RJ . Fact sheet: Nutrients that reduce leadpoisoning. 2010. Accessed at: https://www.lead.org.au/fs/Fact_sheet-Nutrients_that_reduce_lead_poisoning_June_2010.pdf
17. Saraiva MCP, Taichman RS, Braun T, Nriagu J, Eklund SA, Burt BA . Lead exposure and periodontitis in US adults. J Periodont Res 42: 45-52, 2007.
18. Meerwaldt R, Links T, Zeebregts C, Tio R, Hillebrands JL, Smit A. The clinical relevance of
Ali Akbar Malekirad, Razieh Kalantari-Dehaghi and Mohammad Abdollahi
1. Patrick L. Lead toxicity, a review of the literature. Part 1: Exposure, evaluation, and treatment. Altern Med Rev 2006;11:2-22. PMID: 16597190
2. Staudinger KC, Roth VS. Occupational leadpoisoning. Am Fam Physician 1998;57:719-26.
3. Karrari P, Mehrpour O, Abdollahi M. A systematic review on status of lead pollution and toxicity in Iran; Guidance for preventive measures. Daru 2012;20:2. doi: 10.1186/1560-8115-20-2
4. Abdollahi M, Sadeghi Mojarad A, Jalali N. Lead toxicity